Overview

An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model
Phase:
Phase 2
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Analgesics
Ibuprofen